SCHEMBL10094191

SCHEMBL10094191

CC(C)c1cccnc1Nc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 2/20 0.51
▸ MEN1 O00255 8/20 0.51
▸ KMT2A Q03164 8/20 0.51
▸ ALDH1A1 P00352 6/20 0.51
▸ MAPT P10636 4/20 0.51
▸ GAA P10253 1/20 0.51
▸ RAB9A P51151 7/20 0.50
▸ NPC1 O15118 6/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ L3MBTL1 Q9Y468 3/20 0.50
▸ HPGD P15428 2/20 0.48
▸ POLB P06746 1/20 0.48
▸ GRM4 Q14833 1/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ NPSR1 Q6W5P4 2/20 0.45
▸ ABCG2 Q9UNQ0 1/20 0.42
▸ HTT P42858 3/20 0.41
▸ ATM Q13315 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10094180 0.88 NPC1 (0.47) DHODHMEN1KMT2AALDH1A1MAPT
SCHEMBL10094254 0.85 RAB9A (0.54) DHODHMEN1KMT2AALDH1A1RAB9A
SCHEMBL10094192 0.85 DHODH (0.54) DHODHMEN1KMT2AALDH1A1MAPT
SCHEMBL10094166 0.85 CCNA2 (0.48) MEN1KMT2AALDH1A1RAB9ANPC1
SCHEMBL27800317 0.82 DHODH (0.56) DHODHMEN1KMT2AALDH1A1MAPT
SCHEMBL10094204 0.81 HPGD (0.58) DHODHMEN1KMT2AALDH1A1RAB9A
SCHEMBL10094168 0.81 GRM5 (0.58) MEN1KMT2AMAPTGAARAB9A
SCHEMBL10094253 0.80 EGFR (0.46) MEN1KMT2AALDH1A1MAPTRAB9A
SCHEMBL10094260 0.79 ADRA2A (0.45) MEN1KMT2AALDH1A1MAPTGAA
SCHEMBL2739344 0.79 LMNA (0.64) DHODHMEN1KMT2AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148535-B2 Potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2012-04-03 — — US disclosed
US-8148535-B2 Potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2012-04-03 — — US disclosed
US-20090233897-A1 Potassium Channel Inhibitors MERCK SHARP & DOHME CORP. 2009-09-17 — — US disclosed
US-20090233897-A1 Potassium Channel Inhibitors MERCK SHARP & DOHME CORP. 2009-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233897-A1 Potassium Channel Inhibitors KCNJ2, KCNQ2, KCNH2 DHODH 1364/4885MEN1 2152/4885KMT2A 278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback